Accurate Measurement of Cardiac Output Using the Ultrasound Dilution Technique
BCM
2 other identifiers
observational
28
1 country
1
Brief Summary
Accurate cardiac output determination is a commonly used and important index of myocardial performance. The thermodilution method using a pulmonary artery catheter is the most common approach to cardiac output determination; however, placement of the pulmonary artery catheter is not without risk and at times can be problematic. Ultrasound dilution measurement has been shown to correlate with measured cardiac output in animal models and adults, but it has not been validated in pediatric patients. This study will validate the accuracy of ultrasound dilution measurements of cardiac output to thermodilution measurements of cardiac output in pediatric patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2008
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 25, 2009
CompletedFirst Posted
Study publicly available on registry
February 26, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2011
CompletedMay 31, 2012
May 1, 2012
3.2 years
February 25, 2009
May 30, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Validation of cardiac output measured by ultrasound dilution with cardiac output measured by thermodilution.
5-8 minutes minimum
Eligibility Criteria
Any pediatric patient (aged \< 18 years) who has undergone cardiac transplantation and is already scheduled for a biopsy will be offered the opportunity to participate.
You may qualify if:
- Transplant patients undergoing hemodynamic evaluation in the catheterization laboratory that are less than 18 years of age and have structurally normal hearts.
You may not qualify if:
- Patient's age greater than 18 years, and any structural abnormality of the heart.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Texas Children's Hospital
Houston, Texas, 77030, United States
Related Publications (2)
Krivitski NM, Kislukhin VV, Thuramalla NV. Theory and in vitro validation of a new extracorporeal arteriovenous loop approach for hemodynamic assessment in pediatric and neonatal intensive care unit patients. Pediatr Crit Care Med. 2008 Jul;9(4):423-8. doi: 10.1097/01.PCC.0b013e31816c71bc.
PMID: 18496416BACKGROUNDCrittendon I 3rd, Dreyer WJ, Decker JA, Kim JJ. Ultrasound dilution: an accurate means of determining cardiac output in children. Pediatr Crit Care Med. 2012 Jan;13(1):42-6. doi: 10.1097/PCC.0b013e3182196804.
PMID: 21499176RESULT
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffery J Kim, MD
Texas Children's Hospital, Baylor College of Medicine
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 25, 2009
First Posted
February 26, 2009
Study Start
February 1, 2008
Primary Completion
May 1, 2011
Study Completion
May 1, 2011
Last Updated
May 31, 2012
Record last verified: 2012-05